John Maher

Has grant

King’s College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Engineering av?6-targeted fourth generation chimeric antigen receptor (CAR) T-cells for immunotherapy of pancreatic ductal adenocarcinoma

Open Date: 2016-02-01

Close Date: 2019-03-31

Grant: Close

Immunotherapy of Epithelial Ovarian Cancer using Autologous Gamma Delta T-cells

Open Date: 2016-01-01

Close Date: 2019-03-14

Grant: Close

Phase I trial: t4 immunotherapy of squamous cell carcinoma of head and neck (SCCHN)

Open Date: 2015-03-01

Close Date: 2018-04-28

Grant: Close

Development of gamma delta (gd) T-cell immunotherapy for triple negative breast cancer (TNBC)

Open Date: 2015-02-01

Close Date: 2017-01-31

Grant: Close

Maximising the therapeutic index of CAR T-cell immunotherapy of breast cancer

Open Date: 2014-10-01

Close Date: 2015-09-30

Articles (16)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Adjunct Reader

King's College London

UNITED KINGDOM

View details

James Spicer

King’s College London

UNITED KINGDOM

View details

Gary Cook

King’s College London

UNITED KINGDOM

View details

Ninh La-Beck

Texas Tech University Health Sciences Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

John Maher

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (16)

CAR-T cell technologies that interact with the tumour microenvironment in solid tumours

Fusobacterium is toxic for head and neck squamous cell carcinoma and its presence may determine a better prognosis

Granzyme B-activated IL18 potentiates αβ and γδ CAR T cell immunotherapy in a tumor-dependent manner

Bispecific T cell engager-armed T cells targeting integrin ανβ6 exhibit enhanced T cell redirection and antitumor activity in cholangiocarcinoma

Engineering a Dual Specificity γδ T-Cell Receptor for Cancer Immunotherapy

Intra-Tumoral pan-ErbB Targeted CAR-T for Head and Neck Squamous Cell Carcinoma: Interim Analysis of the T4 Immunotherapy Study

The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer

Chimeric Antigen Receptor (CAR) T-Cell Therapy for Patients with Lung Cancer: Current Perspectives

Solid tumours: Building bridges to CAR‐T success

CAR based immunotherapy of solid tumours – a survey of the emerging targets.

CAR Based Immunotherapy of Solid Tumours—A Clinically Based Review of Target Antigens

Harnessing Nanomedicine to Potentiate the Chemo-Immunotherapeutic Effects of Doxorubicin and Alendronate Co-Encapsulated in Pegylated Liposomes.

Prospects for Development of Induced Pluripotent Stem Cell-Derived CAR-Targeted Immunotherapies

CAR T cell immunotherapy of epithelial ovarian cancer: past, present and a view of the horizon

CAR T-Cell Targeting of Macrophage Colony-Stimulating Factor Receptor

Generation of human parallel chimeric antigen receptor (pCAR) T cells to achieve synergistic T cell co-stimulation

Collaborators (11)

Fiona Reid

Anna Schurich

Maria Elstad

Richard Beatson

Sophie Papa

Nick Beckley-Hoelscher

Anthony Kong

Teresa Guerrero Urbano

James Spicer

Gary Cook

Ninh La-Beck

Make your next move.